To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No significant improvement in anterior knee pain with dextrose prolotherapy for Osgood-Schlatter

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2020

No significant improvement in anterior knee pain with dextrose prolotherapy for Osgood-Schlatter

Vol: 9| Issue: 4| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

No superiority of dextrose injections over placebo injections for Osgood-Schlatter disease: a prospective randomized double-blind study.

Arch Orthop Trauma Surg. 2020 Feb;140(2):197-202.

Contributing Authors:
J Nakase Junsuke Nakase Takeshi Oshima T Oshima Y Takata Yasushi Takata Kengo Shimozaki K Shimozaki H Tsuchiya Kazuki Asai Hiroyuki Tsuchiya K Asai

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty-nine knees with Osgood-Schlatter disease were randomized to receive three monthly injections of dextrose or normal saline for the improvement anterior knee pain. The outcome of interest was anterior knee pain, as measured on the Victorian Institute of Sport Assessment (VISA) score. Follow up occurred one, two and three months after the first injection took place. Results of the study reveale...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue